Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
Feb 9, 2022
Document Date
Feb 9, 2022
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.